SCHEMBL640091

SCHEMBL640091

CNC(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetonitrile SCHEMBL27831882 0.87
SCHEMBL19607891 0.81 ALDH1A1 (0.36)
SCHEMBL12564384 0.77 LMNA (0.43)
Phthalic Acid SCHEMBL26699216 0.76 KMT2A (0.57)
SCHEMBL4055120 0.75
SCHEMBL16807522 0.75
SCHEMBL2106440 0.74
SCHEMBL23475924 0.72 TSHR (0.44)
SCHEMBL3660629 0.72 LMNA (0.63)
SCHEMBL8962977 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
CN-114105980-B Preparation method of Lu Meipai-one intermediate compound and lumepiquat chloride intermediate compound 南方科技大学坪山生物医药研究院 2024-04-16 CN claimed
CN-115873031-A Method for preparing omethoate 河南省化工研究所有限责任公司 2023-03-31 CN claimed
CN-114105980-A Preparation method of rumepilone intermediate compound and rumepilone intermediate compound 南方科技大学坪山生物医药研究院 2022-03-01 CN claimed
CN-105130985-A Phenanthroindolizidine alkaloid quaternary ammonium salt derivative and preparation and plant virus resisting application thereof UNIV NANKAI 2015-12-09 CN claimed
CN-103012367-A Quinoline derivative UNIV PEKING FOUNDER GROUP CO 2013-04-03 CN claimed
CN-103012368-A Quinoline derivative UNIV PEKING FOUNDER GROUP CO 2013-04-03 CN claimed
US-20050130228-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2005-06-16 US claimed
US-20030138847-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2003-07-24 US claimed
EP-1268050-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 EP claimed
JP-2002542227-A 2002-12-10 JP claimed
EP-1210322-A1 METHOD FOR CARRYING OUT THE SIDE CHAIN BROMINATION OF 4-METHYL BIPHENYL DERIVATIVES SUBSTITUTED AT THE 2'-POSITION Boehringer Ingelheim Pharma KG (DE) 2002-06-05 EP claimed
WO-2001068598-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 WO claimed
WO-2000063164-A1 METHOD FOR CARRYING OUT THE SIDE CHAIN BROMINATION OF 4-METHYL BIPHENYL DERIVATIVES SUBSTITUTED AT THE 2'-POSITION BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-10-26 WO claimed
CN-122094954-A Tricyclic quinolones and 1, 8-naphthyridin-2-one BCL6 difunctional degrading agents 2026-05-26 CN disclosed
WO-2026107328-A1 AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS SEPTERNA, INC. (US) 2026-05-21 WO disclosed
EP-4743454-A1 PYRIMIDINE COMPOUNDS AND THEIR USE AS USP1 INHIBITORS Laekna Pharmaceutical Ningbo Co., Ltd. (CN) 2026-05-20 EP disclosed
US-4228179-A ANTICONVULSANTS WARNER-LAMBERT COMPANY (US) 1980-10-14 US disclosed
US-4021472-A ANTIPLASMIN AND ANTITRYPSIN ONO PHARMACEUTICAL CO., LTD. (JA) 1977-05-03 US disclosed
US-4008066-A Phenylaminoacetamides for regulating plant growth CIBA-GEIGY CORPORATION (US) 1977-02-15 US disclosed